Research in Context
Essential Research for Clinicians and Healthcare Professionals
Research in Context is a structured summary that editors at The Lancet’s journals ask all authors to provide when submitting an original research article. Read more
Featured Topic
Non-Small Cell Lung Cancer
AENEAS2: aumolertinib–chemotherapy studied as a potential first-line option in EGFR-sensitive mutated NSCLC
Investigators reported significantly improved progression-free survival versus aumolertinib monotherapy, with no new safety signals; the authors describe the combination as a potential first-line alternative, not an established standard.
